AACR: Breastfeeding May Reduce Breast Cancer Risk
LOS ANGELES -- Breastfeeding appears to cancel out the significantly added risk of hormone-negative breast cancer for women who are nulliparous until after age 25, researchers reported here.
LOS ANGELES, April 19 -- Breastfeeding appears to cancel out the significantly added risk of hormone-negative breast cancer for women who are null1parous until after age 25, researchers reported here.
The protective effect of breastfeeding extends to breast tumors that are hormone-receptor-positive as well, said Giske Ursin, M.D., Ph.D., of the University of Southern California in Los Angeles at the American Association for Cancer Research meeting here.
Regardless of maternal age, the protective effective of parity on hormone-positive tumors was only seen among women who breastfed (P for trend= 0.001), not women who never breastfed (P for trend=0.29).
"We believe that breastfeeding should be encouraged for all women," she said. But she cautioned that while she was reporting an association between breastfeeding and reduced cases of breast cancer "we cannot say that breastfeeding is a direct cause and effect for protecting women against breast cancer."
The association emerged from analysis of data from 995 women with incident invasive breast cancer and 1,498 controls.
Dr. Ursin collected age of first pregnancy, parity, and breastfeeding history from both cases and controls. All women were 55 or older and all were participants in the Women's Contraceptive and Reproductive Experiences (CARE) study, a multicenter case-control study of breast cancer in white and African American women.
Seven hundred and twenty-eight women had estrogen- receptor/progesterone-receptor positive tumors and 267 had hormone-negative cancers.
Among the findings:
- Women who gave birth before age 25 had a 41% reduction in risk of developing estrogen- or progesterone- receptor- positive breast cancers (OR= 1.05, 95% CI=0.42-0.82).
- Parity did not reduce risk among women who gave birth after age 25 (OR=1.05, 95% CI=0.73-1.51).
- Those who gave birth at age 25 or after had an increased risk of hormone-negative tumors (OR=2.07, 95% CI=1.03-4.16) and among these women additional pregnancies increased this risk (P for trend=0.03).
- Women who first gave birth at age 25 or later who never breastfed, parity was associated with an increased risk of breast cancer, both for hormone positive (P for trend = 0.04) and hormone negative breast cancer (P trend = 0.02).
3 Reasons Urology Practices Should Add Onsite UTI PCR Labs Under New LCD Rules
March 11th 20251. ONSITE PCR TESTING BRINGS SIGNIFICANT CLINICAL BENEFITS TO A PRACTICE. - ACCURACY Traditional urine cultures can give false-negative results. - SPECIFICITY Accurate microbial identification leads to targeted treatment. - SPEED Same day results vs. 3-5 days for traditional urine cultures - - - ANTIBIOTIC RESISTANCE MARKERS Improves antimicrobial stewardship 2. MAINTAIN INDEPENDENCE BY INCREASING REVENUE SIGNIFICANTLY THROUGH REVENUE SHIFTING FROM THE REFERENCE LAB TO THE PRACTICE. - Turnkey: Consultation on COLA and CLIA certification, all necessary equipment, standard operating procedures, personnel sourcing and interview, billing and coding training, 3-4 days of onsite training. - Stark Law Compliant: Complies with anti-kickback statutes. - Medicare part B pays at 100%, Med Advantage Plans at 80% - No lab build-out, only 8 linear feet of counter space needed - Z-code procurement for required states 3. BETTER PATIENT CARE LEADS TO BETTER OUTCOMES. - CONVENIENCE Point of care, no third-party referral lab. - TIMELY Results early in the care process. - CORRECT MEDICATION Avoids two trips to the pharmacy. - BETTER OUTCOMES Reduction of recurrent UTI and hospitalizations
